血清支链氨基酸水平预测脓毒性休克心血管器官衰竭持续时间
该研究为一项左卡尼汀II期随机对照试验的二次分析,纳入228例脓毒性休克患者(SOFA≥5、乳酸≥2、血管活性药支持≥4小时),采用1H-NMR代谢组学检测血清代谢物。支链氨基酸(缬氨酸、亮氨酸、异亮氨酸)是主要结局的单变量预测因子,其中缬氨酸在控制SOFA评分后仍显著,且48小时BCAA浓度可显著区分休克缓解与持续休克。结论提示BCAA浓度可独立预测休克缓解时间,为脓毒症心血管衰竭的代谢机制提供假设生成数据。
要点
- 在脓毒性休克患者中,血清缬氨酸、亮氨酸、异亮氨酸水平可单变量预测48小时内休克缓解,缬氨酸在控制SOFA评分后仍显著。
- 48小时BCAA浓度能显著区分休克缓解与持续休克患者,提示可作为床旁动态监测的候选标志物。
- 该研究为左卡尼汀II期RCT的二次分析,BCAA与休克缓解的关联属假设生成,尚不能作为治疗靶点推荐。
- 研究排除标准未在摘要中详述,但纳入人群限定为SOFA≥5、乳酸≥2、血管活性药支持≥4小时的脓毒性休克患者。
适用人群与场景
- 纳入标准:脓毒性休克患者,SOFA评分≥5,乳酸≥2,需要血管活性药物支持至少4小时。
- 场景:急诊/ICU收治的脓毒性休克患者,处于血管活性药依赖阶段。
- 排除人群:原文未提及具体排除标准。
诊断标准与关键阈值
- 脓毒性休克诊断依据原文纳入标准:SOFA评分≥5、乳酸≥2、血管活性药支持≥4小时。
- 主要结局为48小时内休克缓解(存活且脱离血管活性药),原文未给出具体休克缓解的血压或血管活性药剂量阈值。
处置流程与药物剂量
- 原文未提及基于BCAA的具体治疗推荐或药物剂量调整方案。
- 原文未提及BCAA检测的时机、频次或目标值用于临床决策。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 研究类型:左卡尼汀II期随机对照试验的二次分析,采用1H-NMR代谢组学。
- 样本量与中心数:228例患者,中心数原文未提及。
- 人群:脓毒性休克患者,SOFA≥5、乳酸≥2、血管活性药支持≥4小时。
- 关键结果:缬氨酸、亮氨酸、异亮氨酸是主要结局的单变量预测因子(经多重假设检验校正后),缬氨酸在控制SOFA评分后仍显著;基于无血管活性药天数分析结果类似,控制混杂变量并排除死亡者后仍持续;48小时BCAA浓度显著区分休克缓解与持续休克。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析(探索性代谢组学分析)。
- 证据等级或推荐强度:原文未提及。
- 局限:二次分析、样本量228例、单中心或多中心未说明、BCAA预测价值属假设生成,需前瞻性验证。
对床旁实践的改变
- 该研究提示BCAA(尤其缬氨酸)可能作为脓毒性休克患者休克缓解的预测标志物,但尚不能改变当前床旁处置流程。
- 不适用人群:非脓毒性休克、未达到纳入标准(SOFA<5、乳酸<2、血管活性药支持<4小时)的患者。
- 常见陷阱:不能将BCAA水平作为启动或停止血管活性药、调整营养或代谢治疗的依据;原文为二次分析,关联不等于因果。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis shifts cardiac metabolic fuel preference and this disruption may have implications for cardiovascular function. A greater understanding of the role of metabolism in the development and persistence of cardiovascular failure in sepsis could serve to identify novel pharmacotherapeutic approaches.
METHODS: Secondary analysis of prospective quantitative proton nuclear magnetic resonance (1H-NMR) metabolomic data from patients enrolled in a phase II randomized control trial of L-carnitine in septic shock. Participants with a sequential organ failure assessment (SOFA) score of > = 5, lactate > = 2, and requiring vasopressor support for at least 4 h were eligible for enrollment. The independent prognostic value of metabolites to predict survival with shock resolution within 48 h and vasopressor free days were assessed. Concentrations of predictive metabolites were compared between participants with and without shock resolution at 48 h.
RESULTS: Serum 1H-NMR metabolomics data from 228 patients were analyzed. Eighty-one (36%) patients met the primary outcome; 33 (14%) died prior to 48 h. The branched chain amino acids (BCAA), valine, leucine, and isoleucine were univariate predictors of the primary outcome after adjusting for multiple hypothesis testing, while valine remained significant after controlling for SOFA score. Similar results were observed when analyzed based on vasopressor free days, and persisted after controlling for confounding variables and excluding non-survivors. BCAA concentrations at 48 h significantly discriminated between those with shock resolution versus persistent shock.
CONCLUSIONS: Among patients with septic shock, BCAA concentrations independently predict time to shock resolution. This study provides hypothesis generating data into the potential contribution of BCAAs to the pathophysiology of cardiovascular failure in sepsis, opening areas for future investigations.
参考来源
- Puskarich MA, McHugh C, Flott TL, et al. Serum Levels of Branched Chain Amino Acids Predict Duration of Cardiovascular Organ Failure in Septic Shock. Shock. 2021. PMID: 33156242. doi:10.1097/SHK.0000000000001687
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。